Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP5-ATP5, February 1, 2024. Introduction:Impact of race on outcomes in the treatment of intracranial aneurysm (IA) remains unclear. The primary outcome was 90-day mRS 0-2.

Aneurysm 40

Aneurysm Outcomes Stroke Strokes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. There is limited data on the influence of COVID‐19 on treatment and outcomes in patients with intracranial aneurysms. From 2016 to 2020, an upward trend in hospitalizations for ischemic stroke was seen among patients treated for IAs (6.1%

COVID-19 40

COVID-19 Aneurysm Outcomes Inpatient 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP256-ATP256, February 1, 2024. Background:While predictors of seizure in aneurysmal subarachnoid hemorrhage (aSAH) patients have been explored, predictors for seizure in patients with angiogram-negative non-perimesencephalic SAH (an-NPSAH) are less understood. per grade increase, 95% CI 1.05-1.49;

Aneurysm 40

Aneurysm Hemorrhage Academic Hospital 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP139-AWP139, February 1, 2024. Background:Cerebral vasospasm is a well-known complication after aneurysmal subarachnoid hemorrhage (aSAH) and occurs more commonly in younger patients. Vasospasm was defined based on transcranial Doppler (TCD) criteria.

Atherosclerosis 40

Atherosclerosis Aneurysm Hemorrhage Outcomes 40

Journal of the American Heart Association

FEBRUARY 14, 2024

BackgroundPatent foramen ovale (PFO) is causally associated with stroke in some patients younger than 60 years, especially when it is large or associated with an atrial septal aneurysm (ASA). Among 533 patients (median National Institutes of Health Stroke Scale score=1), PFO was present in 152 (prevalence, 28.5% [95% CI, 24.9–32.5]).

Anatomy 45

Anatomy Stroke Strokes Aneurysm 45

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP34-ATP34, February 1, 2024. Comparative outcome analyses between pre-COVID (2016-2019) and COVID year (2020) were performed. Background:Hemorrhagic cerebrovascular manifestations are known to be associated with COVID-19. years with 72,650 (61.0%) being female.

COVID-19 40

COVID-19 Hemorrhage Outcomes Inpatient 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP19-ATP19, February 1, 2024. This study aims to describe outcomes and determinants of outcomes in pediatric patients with SAH.Methods:We reviewed all pediatric admissions with the primary diagnosis of SAH from the 2016-2020 National Inpatient Sample using International Classification of Disease Codes.

Pediatrics 40

Pediatrics Hemorrhage Outcomes Hospital 40